Delivery Order SPE2DB22D9251-SPE2DB25FR1JS
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,700.56 by the Defense Logistics Agency (DLA) for the supply of Botox 100 unit vials. This firm fixed-price delivery order, awarded on August 14, 2025, with an ultimate completion date of September 5, 2025, was issued without a set-aside designation. The contract is performed at the contractor's facility in Park Ridge, Illinois, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for BOTOX 200 Unit Vials with a ceiling value of $3,881.10. The award was issued on September 3, 2025, with an ultimate completion date of September 24, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, leveraging DMS Pharmaceutical Group's established position...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $38,811.00 by the Defense Logistics Agency on September 8, 2025, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, with an ultimate completion date of September 29, 2025, was issued without a set-aside designation. The award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,293.72 by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Botox 200 unit vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, and does not utilize a set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48.6K on July 22, 2025, for the supply of Botox 100 Unit Vials. The contract utilizes a firm fixed-price delivery model with an ultimate completion date of August 12, 2025, and was funded by the Defense Logistics Agency's Medical Supply Chain division. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Botox 100 unit vials. This firm fixed-price delivery order, valued at $11,101.68, is scheduled for completion by September 18, 2025, and represents performance to be delivered at the contractor's Park Ridge, Illinois location. The award was made without a set-aside designation,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, valued at $64.7K with an ultimate completion date of September 18, 2025, carries no set-aside designation. The award represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on August 18, 2025, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, valued at $6,468.50 with completion targeted for September 9, 2025, represents a continuation of the company's extensive pharmaceutical supply relationship with the Department of Defense. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order for BOTOX 200 unit vials valued at $7.76K by the Defense Logistics Agency (DLA) on August 18, 2025, with an ultimate completion date of September 9, 2025. The contract utilizes firm fixed-price pricing and does not employ a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,587.40 by the Defense Logistics Agency (DLA) on August 14, 2025, for the supply of Botox 200 Unit Vials. The contract carries a firm fixed-price structure with an ultimate completion date of September 5, 2025, and was awarded without any set-aside designation. Performance will take place at the vendor's Park Ridge, Illinois location....
- SPE2DB22D9251Indefinite Delivery Contract
- SPE2DB22D9251-SPE2DB25FR1JSDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Botox 200-unit vials with a ceiling value of $3,881.10. This firm fixed-price delivery order, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026. The delivery order does not utilize a set-aside designation, and performance will take place at the contractor's facility in Park Ridge, Illinois. This award represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, particularly for the Department of Defense healthcare system. The SPE2DB indefinite delivery contract vehicle enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical products, including biologics and specialty medications, supporting medical supply needs of military health facilities worldwide. Botox, classified as a specialty pharmaceutical product, falls within the contract's broad pharmaceutical portfolio and serves to support medical and healthcare operations across the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/10/25 |